ID   CHIT1_HUMAN             Reviewed;         466 AA.
AC   Q13231; B3KNW6; J3KN09; Q0VGG5; Q0VGG6; Q3ZAR1; Q6ISC2; Q9H3V8;
AC   Q9UDJ8;
DT   24-OCT-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   10-MAY-2017, entry version 170.
DE   RecName: Full=Chitotriosidase-1;
DE            EC=3.2.1.14;
DE   AltName: Full=Chitinase-1;
DE   Flags: Precursor;
GN   Name=CHIT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, AND
RP   SUBCELLULAR LOCATION.
RC   TISSUE=Macrophage;
RX   PubMed=7592832; DOI=10.1074/jbc.270.44.26252;
RA   Boot R.G., Renkema G.H., Strijland A., van Zonneveld A.J.,
RA   Aerts J.M.F.G.;
RT   "Cloning of a cDNA encoding chitotriosidase, a human chitinase
RT   produced by macrophages.";
RL   J. Biol. Chem. 270:26252-26256(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), AND VARIANT
RP   GLY-442.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS
RP   SER-102 AND GLY-442.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 22-43 AND 178-198, FUNCTION, CATALYTIC ACTIVITY,
RP   AND TISSUE SPECIFICITY.
RC   TISSUE=Spleen;
RX   PubMed=7836450; DOI=10.1074/jbc.270.5.2198;
RA   Renkema G.H., Boot R.G., Muijsers A.O., Donker-Koopman W.E.,
RA   Aerts J.M.F.G.;
RT   "Purification and characterization of human chitotriosidase, a novel
RT   member of the chitinase family of proteins.";
RL   J. Biol. Chem. 270:2198-2202(1995).
RN   [6]
RP   POLYMORPHISM, AND FUNCTION (ISOFORM 3).
RX   PubMed=9748235; DOI=10.1074/jbc.273.40.25680;
RA   Boot R.G., Renkema G.H., Verhoek M., Strijland A., Bliek J.,
RA   de Meulemeester T.M.A.M.O., Mannens M.M.A.M., Aerts J.M.F.G.;
RT   "The human chitotriosidase gene. Nature of inherited enzyme
RT   deficiency.";
RL   J. Biol. Chem. 273:25680-25685(1998).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 22-386 IN COMPLEX WITH
RP   CHITOBIOSE AND ALLOSAMIDIN, SUBCELLULAR LOCATION, AND DISULFIDE BONDS.
RX   PubMed=11960986; DOI=10.1074/jbc.M201636200;
RA   Fusetti F., von Moeller H., Houston D., Rozeboom H.J., Dijkstra B.W.,
RA   Boot R.G., Aerts J.M.F.G., van Aalten D.M.F.;
RT   "Structure of human chitotriosidase. Implications for specific
RT   inhibitor design and function of mammalian chitinase-like lectins.";
RL   J. Biol. Chem. 277:25537-25544(2002).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 22-385 IN COMPLEX WITH
RP   ALLOSAMIDIN.
RX   PubMed=12639956; DOI=10.1074/jbc.M300362200;
RA   Rao F.V., Houston D.R., Boot R.G., Aerts J.M., Sakuda S.,
RA   van Aalten D.M.;
RT   "Crystal structures of allosamidin derivatives in complex with human
RT   macrophage chitinase.";
RL   J. Biol. Chem. 278:20110-20116(2003).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) OF 22-466 IN COMPLEX WITH THE
RP   CYCLOPENTAPEPTIDE INHIBITOR ARGADIN, AND CATALYTIC ACTIVITY.
RX   PubMed=15664516; DOI=10.1016/j.chembiol.2004.10.013;
RA   Rao F.V., Houston D.R., Boot R.G., Aerts J.M., Hodkinson M.,
RA   Adams D.J., Shiomi K., Omura S., van Aalten D.M.;
RT   "Specificity and affinity of natural product cyclopentapeptide
RT   inhibitors against A. fumigatus, human, and bacterial chitinases.";
RL   Chem. Biol. 12:65-76(2005).
RN   [10]
RP   VARIANTS LYS-74 AND SER-102.
RX   PubMed=17464953; DOI=10.1002/humu.20524;
RA   Grace M.E., Balwani M., Nazarenko I., Prakash-Cheng A., Desnick R.J.;
RT   "Type 1 Gaucher disease: null and hypomorphic novel chitotriosidase
RT   mutations-implications for diagnosis and therapeutic monitoring.";
RL   Hum. Mutat. 28:866-873(2007).
RN   [11]
RP   CHARACTERIZATION OF VARIANT SER-102, SUBCELLULAR LOCATION, CATALYTIC
RP   ACTIVITY, AND GLYCOSYLATION AT ASN-100.
RX   PubMed=19725875; DOI=10.1111/j.1742-4658.2009.07259.x;
RA   Bussink A.P., Verhoek M., Vreede J., Ghauharali-van der Vlugt K.,
RA   Donker-Koopman W.E., Sprenger R.R., Hollak C.E., Aerts J.M.,
RA   Boot R.G.;
RT   "Common G102S polymorphism in chitotriosidase differentially affects
RT   activity towards 4-methylumbelliferyl substrates.";
RL   FEBS J. 276:5678-5688(2009).
CC   -!- FUNCTION: Degrades chitin, chitotriose and chitobiose. May
CC       participate in the defense against nematodes and other pathogens.
CC       Isoform 3 has no enzymatic activity. {ECO:0000269|PubMed:7592832,
CC       ECO:0000269|PubMed:7836450}.
CC   -!- CATALYTIC ACTIVITY: Random endo-hydrolysis of N-acetyl-beta-D-
CC       glucosaminide (1->4)-beta-linkages in chitin and chitodextrins.
CC       {ECO:0000269|PubMed:15664516, ECO:0000269|PubMed:19725875,
CC       ECO:0000269|PubMed:7836450}.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:11960986,
CC       ECO:0000269|PubMed:12639956, ECO:0000269|PubMed:15664516}.
CC   -!- SUBCELLULAR LOCATION: Secreted. Lysosome. Note=A small proportion
CC       is lysosomal.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q13231-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q13231-2; Sequence=VSP_008631, VSP_008632;
CC       Name=3;
CC         IsoId=Q13231-3; Sequence=VSP_008633;
CC         Note=Duplication of 24 bp in exon 10 leads to the use of a
CC         cryptic splice site. The normal splice site is still present but
CC         not used.;
CC       Name=4;
CC         IsoId=Q13231-4; Sequence=VSP_044816;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Detected in spleen. Secreted by cultured
CC       macrophages. {ECO:0000269|PubMed:7836450}.
CC   -!- POLYMORPHISM: A 24 bp duplication in exon 10 leads to the
CC       activation of an alternative splice site and the production of an
CC       inactive protein resulting in chitotriosidase deficiency
CC       [MIM:614122]. About 6% of the population are deficient for CHIT1
CC       activity, while 35% are carriers and show reduced enzyme levels.
CC       People with CHIT1 deficiency appear perfectly healthy.
CC       {ECO:0000269|PubMed:9748235}.
CC   -!- MISCELLANEOUS: Very high plasma levels of CHIT1 are found in
CC       patients with Gaucher disease type 1 (GD I). Can be used as
CC       diagnostic aid and to evaluate the success of treatment that
CC       brings levels back to normal.
CC   -!- SIMILARITY: Belongs to the glycosyl hydrolase 18 family. Chitinase
CC       class II subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAG51478.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U29615; AAC50246.1; -; mRNA.
DR   EMBL; U62662; AAG10644.1; -; mRNA.
DR   EMBL; AK055165; BAG51478.1; ALT_INIT; mRNA.
DR   EMBL; AC105940; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL359090; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC069614; AAH69614.1; -; mRNA.
DR   EMBL; BC103695; AAI03696.1; -; mRNA.
DR   EMBL; BC105680; AAI05681.1; -; mRNA.
DR   EMBL; BC105681; AAI05682.1; -; mRNA.
DR   EMBL; BC105682; AAI05683.1; -; mRNA.
DR   CCDS; CCDS1436.1; -. [Q13231-1]
DR   CCDS; CCDS58057.1; -. [Q13231-4]
DR   RefSeq; NP_001243054.2; NM_001256125.1. [Q13231-4]
DR   RefSeq; NP_003456.1; NM_003465.2. [Q13231-1]
DR   UniGene; Hs.201688; -.
DR   PDB; 1GUV; X-ray; 2.35 A; A=22-387.
DR   PDB; 1HKI; X-ray; 2.55 A; A=22-386.
DR   PDB; 1HKJ; X-ray; 2.60 A; A=22-386.
DR   PDB; 1HKK; X-ray; 1.85 A; A=22-385.
DR   PDB; 1HKM; X-ray; 2.55 A; A=22-386.
DR   PDB; 1LG1; X-ray; 2.78 A; A=22-386.
DR   PDB; 1LG2; X-ray; 2.10 A; A=22-386.
DR   PDB; 1LQ0; X-ray; 2.20 A; A=22-386.
DR   PDB; 1WAW; X-ray; 1.75 A; A=22-466.
DR   PDB; 1WB0; X-ray; 1.65 A; A=22-466.
DR   PDB; 4WJX; X-ray; 1.00 A; A=22-387.
DR   PDB; 4WK9; X-ray; 1.10 A; A=22-387.
DR   PDB; 4WKA; X-ray; 0.95 A; A=22-386.
DR   PDB; 4WKF; X-ray; 1.10 A; A=22-387.
DR   PDB; 4WKH; X-ray; 1.05 A; A=22-387.
DR   PDB; 5HBF; X-ray; 1.95 A; A/B=1-466.
DR   PDBsum; 1GUV; -.
DR   PDBsum; 1HKI; -.
DR   PDBsum; 1HKJ; -.
DR   PDBsum; 1HKK; -.
DR   PDBsum; 1HKM; -.
DR   PDBsum; 1LG1; -.
DR   PDBsum; 1LG2; -.
DR   PDBsum; 1LQ0; -.
DR   PDBsum; 1WAW; -.
DR   PDBsum; 1WB0; -.
DR   PDBsum; 4WJX; -.
DR   PDBsum; 4WK9; -.
DR   PDBsum; 4WKA; -.
DR   PDBsum; 4WKF; -.
DR   PDBsum; 4WKH; -.
DR   PDBsum; 5HBF; -.
DR   ProteinModelPortal; Q13231; -.
DR   SMR; Q13231; -.
DR   BioGrid; 107542; 4.
DR   STRING; 9606.ENSP00000356198; -.
DR   BindingDB; Q13231; -.
DR   ChEMBL; CHEMBL3080; -.
DR   DrugBank; DB03539; 2-(Acetylamino)-2-Deoxy-6-O-Methyl-Alpha-D-Allopyranose.
DR   DrugBank; DB04404; Allosamizoline.
DR   DrugBank; DB04350; Argadin.
DR   DrugBank; DB03632; Argifin.
DR   DrugBank; DB02325; Isopropyl Alcohol.
DR   DrugBank; DB03109; N-Acetyl-D-Allosamine.
DR   CAZy; CBM14; Carbohydrate-Binding Module Family 14.
DR   CAZy; GH18; Glycoside Hydrolase Family 18.
DR   iPTMnet; Q13231; -.
DR   PhosphoSitePlus; Q13231; -.
DR   BioMuta; CHIT1; -.
DR   DMDM; 37999493; -.
DR   PaxDb; Q13231; -.
DR   PeptideAtlas; Q13231; -.
DR   PRIDE; Q13231; -.
DR   DNASU; 1118; -.
DR   Ensembl; ENST00000255427; ENSP00000255427; ENSG00000133063. [Q13231-4]
DR   Ensembl; ENST00000367229; ENSP00000356198; ENSG00000133063. [Q13231-1]
DR   Ensembl; ENST00000491855; ENSP00000423778; ENSG00000133063. [Q13231-2]
DR   GeneID; 1118; -.
DR   KEGG; hsa:1118; -.
DR   UCSC; uc001gzn.3; human. [Q13231-1]
DR   CTD; 1118; -.
DR   DisGeNET; 1118; -.
DR   GeneCards; CHIT1; -.
DR   HGNC; HGNC:1936; CHIT1.
DR   HPA; HPA010575; -.
DR   MalaCards; CHIT1; -.
DR   MIM; 600031; gene.
DR   MIM; 614122; phenotype.
DR   neXtProt; NX_Q13231; -.
DR   OpenTargets; ENSG00000133063; -.
DR   PharmGKB; PA26467; -.
DR   eggNOG; KOG2806; Eukaryota.
DR   eggNOG; COG3325; LUCA.
DR   GeneTree; ENSGT00550000074323; -.
DR   HOVERGEN; HBG011684; -.
DR   InParanoid; Q13231; -.
DR   KO; K01183; -.
DR   OMA; RSSFYSC; -.
DR   OrthoDB; EOG091G014W; -.
DR   PhylomeDB; Q13231; -.
DR   TreeFam; TF315610; -.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-71387; Metabolism of carbohydrates.
DR   ChiTaRS; CHIT1; human.
DR   EvolutionaryTrace; Q13231; -.
DR   GenomeRNAi; 1118; -.
DR   PRO; PR:Q13231; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000133063; -.
DR   CleanEx; HS_CHIT1; -.
DR   ExpressionAtlas; Q13231; baseline and differential.
DR   Genevisible; Q13231; HS.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0005764; C:lysosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0035580; C:specific granule lumen; TAS:Reactome.
DR   GO; GO:1904724; C:tertiary granule lumen; TAS:Reactome.
DR   GO; GO:0008061; F:chitin binding; TAS:UniProtKB.
DR   GO; GO:0004568; F:chitinase activity; TAS:UniProtKB.
DR   GO; GO:0008843; F:endochitinase activity; IDA:UniProtKB.
DR   GO; GO:0004553; F:hydrolase activity, hydrolyzing O-glycosyl compounds; TAS:Reactome.
DR   GO; GO:0005975; P:carbohydrate metabolic process; TAS:Reactome.
DR   GO; GO:0006032; P:chitin catabolic process; IDA:UniProtKB.
DR   GO; GO:0006955; P:immune response; NAS:UniProtKB.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0000272; P:polysaccharide catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0009617; P:response to bacterium; TAS:ProtInc.
DR   Gene3D; 2.170.140.10; -; 1.
DR   Gene3D; 3.10.50.10; -; 1.
DR   InterPro; IPR002557; Chitin-bd_dom.
DR   InterPro; IPR011583; Chitinase_II.
DR   InterPro; IPR029070; Chitinase_insertion.
DR   InterPro; IPR001223; Glyco_hydro18_cat.
DR   InterPro; IPR001579; Glyco_hydro_18_chit_AS.
DR   InterPro; IPR017853; Glycoside_hydrolase_SF.
DR   Pfam; PF01607; CBM_14; 1.
DR   Pfam; PF00704; Glyco_hydro_18; 1.
DR   SMART; SM00494; ChtBD2; 1.
DR   SMART; SM00636; Glyco_18; 1.
DR   SUPFAM; SSF51445; SSF51445; 2.
DR   SUPFAM; SSF54556; SSF54556; 1.
DR   SUPFAM; SSF57625; SSF57625; 1.
DR   PROSITE; PS50940; CHIT_BIND_II; 1.
DR   PROSITE; PS01095; CHITINASE_18; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Carbohydrate metabolism;
KW   Chitin degradation; Chitin-binding; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein; Glycosidase;
KW   Hydrolase; Lysosome; Polymorphism; Polysaccharide degradation;
KW   Reference proteome; Secreted; Signal.
FT   SIGNAL        1     21       {ECO:0000269|PubMed:7836450}.
FT   CHAIN        22    466       Chitotriosidase-1.
FT                                /FTId=PRO_0000011941.
FT   DOMAIN      417    466       Chitin-binding type-2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00144}.
FT   REGION       70     71       Chitooligosaccharide binding.
FT   REGION       97    100       Chitooligosaccharide binding.
FT   REGION      210    213       Chitooligosaccharide binding.
FT   ACT_SITE    140    140       Proton donor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10053}.
FT   BINDING     269    269       Chitooligosaccharide.
FT   BINDING     358    358       Chitooligosaccharide.
FT   CARBOHYD    100    100       N-linked (GlcNAc...) asparagine; in
FT                                variant S-102.
FT                                {ECO:0000269|PubMed:19725875}.
FT   DISULFID     26     51       {ECO:0000255|PROSITE-ProRule:PRU00144,
FT                                ECO:0000269|PubMed:11960986}.
FT   DISULFID    307    370       {ECO:0000255|PROSITE-ProRule:PRU00144,
FT                                ECO:0000269|PubMed:11960986}.
FT   DISULFID    450    463       {ECO:0000255|PROSITE-ProRule:PRU00144}.
FT   VAR_SEQ      87    105       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044816.
FT   VAR_SEQ     344    372       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_008633.
FT   VAR_SEQ     386    387       SL -> NG (in isoform 2).
FT                                {ECO:0000303|PubMed:7592832}.
FT                                /FTId=VSP_008631.
FT   VAR_SEQ     388    466       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:7592832}.
FT                                /FTId=VSP_008632.
FT   VARIANT      40     40       R -> H (in dbSNP:rs35920428).
FT                                /FTId=VAR_049190.
FT   VARIANT      74     74       E -> K (rare variant detected in patients
FT                                with Gaucher disease type 1;
FT                                dbSNP:rs137852607).
FT                                {ECO:0000269|PubMed:17464953}.
FT                                /FTId=VAR_065914.
FT   VARIANT     102    102       G -> S (common variant detected in
FT                                patients with Gaucher disease type 1 as
FT                                well as healthy individuals; slightly
FT                                reduced activity towards 4-
FT                                methylumbelliferyl-chitotrioside but no
FT                                effect on activity towards 4-
FT                                methylumbelliferyl-deoxychitobioside;
FT                                dbSNP:rs2297950).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17464953,
FT                                ECO:0000269|PubMed:19725875}.
FT                                /FTId=VAR_022138.
FT   VARIANT     171    171       Q -> H (in dbSNP:rs12562058).
FT                                /FTId=VAR_049191.
FT   VARIANT     442    442       A -> G (in dbSNP:rs1065761).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_024458.
FT   STRAND       23     29       {ECO:0000244|PDB:4WKA}.
FT   HELIX        32     34       {ECO:0000244|PDB:4WKA}.
FT   HELIX        37     39       {ECO:0000244|PDB:4WKA}.
FT   HELIX        43     45       {ECO:0000244|PDB:4WKA}.
FT   TURN         48     50       {ECO:0000244|PDB:4WKH}.
FT   STRAND       52     62       {ECO:0000244|PDB:4WKA}.
FT   STRAND       65     67       {ECO:0000244|PDB:4WKA}.
FT   HELIX        73     86       {ECO:0000244|PDB:4WKA}.
FT   STRAND       91     97       {ECO:0000244|PDB:4WKA}.
FT   TURN         99    101       {ECO:0000244|PDB:4WKA}.
FT   HELIX       104    110       {ECO:0000244|PDB:4WKA}.
FT   HELIX       113    130       {ECO:0000244|PDB:4WKA}.
FT   STRAND      133    138       {ECO:0000244|PDB:4WKA}.
FT   STRAND      144    146       {ECO:0000244|PDB:1HKI}.
FT   HELIX       151    173       {ECO:0000244|PDB:4WKA}.
FT   STRAND      179    185       {ECO:0000244|PDB:4WKA}.
FT   HELIX       188    194       {ECO:0000244|PDB:4WKA}.
FT   HELIX       197    201       {ECO:0000244|PDB:4WKA}.
FT   STRAND      205    210       {ECO:0000244|PDB:4WKA}.
FT   STRAND      219    221       {ECO:0000244|PDB:4WKA}.
FT   HELIX       236    240       {ECO:0000244|PDB:4WKA}.
FT   HELIX       243    252       {ECO:0000244|PDB:4WKA}.
FT   HELIX       257    259       {ECO:0000244|PDB:4WKA}.
FT   STRAND      260    274       {ECO:0000244|PDB:4WKA}.
FT   STRAND      284    288       {ECO:0000244|PDB:4WKA}.
FT   TURN        293    295       {ECO:0000244|PDB:4WKA}.
FT   STRAND      300    302       {ECO:0000244|PDB:4WKA}.
FT   HELIX       303    306       {ECO:0000244|PDB:4WKA}.
FT   STRAND      313    317       {ECO:0000244|PDB:4WKA}.
FT   TURN        318    321       {ECO:0000244|PDB:4WKA}.
FT   STRAND      322    327       {ECO:0000244|PDB:4WKA}.
FT   STRAND      330    333       {ECO:0000244|PDB:4WKA}.
FT   HELIX       337    349       {ECO:0000244|PDB:4WKA}.
FT   STRAND      353    358       {ECO:0000244|PDB:4WKA}.
FT   HELIX       360    362       {ECO:0000244|PDB:4WKA}.
FT   STRAND      367    372       {ECO:0000244|PDB:4WKA}.
FT   HELIX       376    384       {ECO:0000244|PDB:4WKA}.
FT   TURN        419    422       {ECO:0000244|PDB:5HBF}.
FT   STRAND      425    430       {ECO:0000244|PDB:5HBF}.
FT   STRAND      433    441       {ECO:0000244|PDB:5HBF}.
FT   STRAND      444    449       {ECO:0000244|PDB:5HBF}.
FT   STRAND      455    457       {ECO:0000244|PDB:5HBF}.
FT   TURN        458    461       {ECO:0000244|PDB:5HBF}.
FT   STRAND      462    464       {ECO:0000244|PDB:5HBF}.
SQ   SEQUENCE   466 AA;  51681 MW;  B4312D1E885E386D CRC64;
     MVRSVAWAGF MVLLMIPWGS AAKLVCYFTN WAQYRQGEAR FLPKDLDPSL CTHLIYAFAG
     MTNHQLSTTE WNDETLYQEF NGLKKMNPKL KTLLAIGGWN FGTQKFTDMV ATANNRQTFV
     NSAIRFLRKY SFDGLDLDWE YPGSQGSPAV DKERFTTLVQ DLANAFQQEA QTSGKERLLL
     SAAVPAGQTY VDAGYEVDKI AQNLDFVNLM AYDFHGSWEK VTGHNSPLYK RQEESGAAAS
     LNVDAAVQQW LQKGTPASKL ILGMPTYGRS FTLASSSDTR VGAPATGSGT PGPFTKEGGM
     LAYYEVCSWK GATKQRIQDQ KVPYIFRDNQ WVGFDDVESF KTKVSYLKQK GLGGAMVWAL
     DLDDFAGFSC NQGRYPLIQT LRQELSLPYL PSGTPELEVP KPGQPSEPEH GPSPGQDTFC
     QGKADGLYPN PRERSSFYSC AAGRLFQQSC PTGLVFSNSC KCCTWN
//
